Trials / Completed
CompletedNCT04667507
Pharmacokinetics of Aqueous Dexamethasone
The Pharmacokinetics of Aqueous Dexamethasone and the Inflammatory Cytokine Response After Treatment with a Dexamethasone Intracanalicular Insert - the CYTODEX Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Frank A. Bucci, Jr., M.D. · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being done to measure the absorption of the DEXTENZA implant and inflammation concentration levels in the eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone Ophthalmic implant | Dexamethasone ophthalmic insert 0.4 mg for intracanalicular use |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-10-31
- Completion
- 2022-06-22
- First posted
- 2020-12-14
- Last updated
- 2024-10-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04667507. Inclusion in this directory is not an endorsement.